Bicocca Open Archive

Logo unimib boa
PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.951
AS - Asia 5.366
EU - Europa 5.178
SA - Sud America 934
AF - Africa 109
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 22.557
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.728
SG - Singapore 1.988
CN - Cina 1.457
IT - Italia 1.084
HK - Hong Kong 914
RU - Federazione Russa 854
DE - Germania 822
BR - Brasile 772
SE - Svezia 572
IE - Irlanda 513
VN - Vietnam 394
UA - Ucraina 313
GB - Regno Unito 246
AT - Austria 214
FR - Francia 151
CA - Canada 142
IN - India 122
FI - Finlandia 107
KR - Corea 84
AR - Argentina 70
TR - Turchia 70
JP - Giappone 69
DK - Danimarca 63
NL - Olanda 62
BD - Bangladesh 61
ID - Indonesia 60
MX - Messico 51
ZA - Sudafrica 48
ES - Italia 43
IQ - Iraq 38
PL - Polonia 29
CO - Colombia 25
SA - Arabia Saudita 24
EC - Ecuador 17
EG - Egitto 16
BE - Belgio 15
PY - Paraguay 15
UZ - Uzbekistan 15
GR - Grecia 14
CH - Svizzera 12
LT - Lituania 12
PT - Portogallo 12
PE - Perù 11
VE - Venezuela 11
PK - Pakistan 10
IR - Iran 8
MA - Marocco 8
AU - Australia 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
PA - Panama 7
CL - Cile 6
IL - Israele 6
JM - Giamaica 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
EU - Europa 5
KZ - Kazakistan 5
TN - Tunisia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
MY - Malesia 4
NO - Norvegia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
BG - Bulgaria 3
CR - Costa Rica 3
HU - Ungheria 3
LV - Lettonia 3
PS - Palestinian Territory 3
RO - Romania 3
RS - Serbia 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
HR - Croazia 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MM - Myanmar 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
TW - Taiwan 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
BZ - Belize 1
CI - Costa d'Avorio 1
EE - Estonia 1
Totale 22.540
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.328
Singapore 1.273
Ashburn 914
Hong Kong 910
Fairfield 670
Woodbridge 670
Chandler 562
Dallas 501
Dublin 496
Frankfurt am Main 482
Houston 481
Wilmington 471
Jacksonville 298
Seattle 297
New York 275
Beijing 262
Dearborn 261
Milan 246
Cambridge 222
Princeton 194
Vienna 193
Hefei 184
Santa Clara 183
Los Angeles 154
Nanjing 142
Ho Chi Minh City 122
Lawrence 92
Altamura 91
The Dalles 82
Seoul 79
São Paulo 78
Hanoi 76
Moscow 74
Chicago 72
Shanghai 68
Buffalo 65
San Diego 55
Dong Ket 48
Jakarta 48
Guangzhou 47
Lachine 43
Nanchang 43
Rome 38
Falls Church 37
London 37
Boardman 36
Tokyo 34
Munich 33
Lissone 32
Shenyang 32
Andover 31
Jinan 31
Nuremberg 30
Helsinki 29
Council Bluffs 28
Tianjin 28
Changsha 26
Pune 26
Brooklyn 25
Salt Lake City 25
Ottawa 24
Zhengzhou 24
Columbus 22
Toronto 22
Montreal 21
Tampa 21
Hebei 20
Belo Horizonte 19
Haiphong 19
Ningbo 19
Warsaw 19
Hangzhou 18
Johannesburg 18
Atlanta 17
Rio de Janeiro 17
Turku 17
Kunming 16
Norwalk 16
Brussels 15
Denver 15
Fremont 15
Jiaxing 15
Monza 15
Manchester 14
Stockholm 14
Tashkent 14
Baghdad 13
Brasília 13
Campinas 13
Dhaka 13
Düsseldorf 13
Huizen 13
Mexico City 13
Phoenix 13
Redmond 13
Boston 12
Chennai 12
Edmonton 12
Kent 12
Kocaeli 12
Totale 15.053
Salva come PNG Salva come JPEG
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 593
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 459
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 446
The putative role of MALDI-MSI in the study of Membranous Nephropathy 385
Microscopic Polyangiitis 358
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 348
MALDI imaging in Fabry nephropathy: a multicenter study 347
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 342
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 331
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 326
Kidney Involvement 320
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 314
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 308
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 307
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 303
Proteomics for the study of new biomarkers in Fabry disease: State of the art 283
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 270
Usefulness of waist circumference for the identification of childhood hypertension 263
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 251
Obesity-associated hypertension in childhood: A new epidemic problem 251
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 249
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 246
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 243
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 243
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 242
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 242
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 241
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 240
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 238
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 221
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 220
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 218
Role of fat distribution indicators in the identification of hypertension in children 216
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 213
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 212
Parapelvic cysts, a distinguishing feature of renal Fabry disease 211
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 208
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 208
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 208
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 206
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 206
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 205
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 204
Sympathetic activation in cardiovascular and renal disease 202
Renal afferents signaling diuretic activity in the cat 198
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 195
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 195
Protein-Bound Uremic Toxins and Inflammation Process in Hemodialysis Patients: Is There a Role for Adsorption Hemodiafiltration? 193
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 192
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 189
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 189
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 188
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 188
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 187
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 185
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 184
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 183
Anticoagulant-related nephropathy: a pathological note 182
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 181
ANCA-associated vasculitis in childhood: Recent advances 177
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 173
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 172
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 171
Tumour incidence in Fabry disease: A cross-sectional study 170
Hypertension in childhood: autonomic and metabolic patterns 169
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 169
La terapia enzimatica sostitutiva nella malattia di Fabry 168
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 166
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 166
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 165
Analysis of heart period and arterial pressure variability in childhood hypertension: Key role of baroreflex impairment 163
La diagnosi precoce di malattia 163
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 160
Redefining the pulvinar sign in fabry disease 159
[Clinical and histological findings in Fabry nephropathy] 157
Avacopan for the treatment of ANCA-associated vasculitis 156
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 156
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 154
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 153
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 153
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 153
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 153
Interpretation of GFR slope in untreated and treated adult Fabry patients 148
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 145
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 145
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 144
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 140
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 138
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 137
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 134
PICC insertion and veins of the arm size variation during dialysis treatment: A prospective observational study 131
The children of dialysis: Live-born babies from on-dialysis mothers in Italy - An epidemiological perspective comparing dialysis, kidney transplantation and the overall population 131
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 126
Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study 122
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 122
Cardiological follow-up in patients with Fabry disease 122
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial 121
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 117
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 117
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 116
Totale 21.078
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.039
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.620 0 0 0 0 0 251 278 308 218 215 148 202
2021/20221.614 155 198 187 148 115 140 47 81 73 91 117 262
2022/20232.290 255 725 192 177 154 357 27 115 157 15 55 61
2023/20241.660 56 46 53 81 191 506 288 56 119 31 42 191
2024/20254.413 266 395 261 189 345 148 270 133 511 813 402 680
2025/20265.280 1.145 705 1.059 976 1.185 210 0 0 0 0 0 0
Totale 23.147